May 2 |
Schrodinger gets rights to cancer drug candidate back from Bristol
|
May 2 |
Biotech Stock Roundup: GILD's GSK' Q1 Earnings, DCPH Soars on Acquisition News & More
|
May 1 |
Editas, Bristol Myers extend T cell therapy collaboration
|
May 1 |
Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell Collaboration
|
Apr 30 |
Bristol-Myers Squibb Company (NYSE:BMY) Q1 2024 Earnings Call Transcript
|
Apr 30 |
J&J, Bristol Myers latest to lose bids to halt Medicare price negotiations
|
Apr 30 |
Bristol Myers Squibb: Tough Times Continue
|
Apr 29 |
J&J, Bristol Myers lose challenges to US drug price negotiation program
|
Apr 29 |
Bristol Myers, Repertoire to develop tolerizing vaccines in multi-year pact
|
Apr 29 |
Repertoire® Immune Medicines and Bristol Myers Squibb Announce Multi-Year Strategic Collaboration to Develop Tolerizing Vaccines for Autoimmune Diseases
|